We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$656M
AUM Growth
-$31.7M
Cap. Flow
-$44.4M
Cap. Flow %
-6.77%
Top 10 Hldgs %
63.24%
Holding
31
New
5
Increased
8
Reduced
14
Closed
3

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$23.4M
2
LLY icon
Eli Lilly
LLY
+$20M
3
NUVA
NuVasive, Inc.
NUVA
+$12.1M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$11.7M
5
BIIB icon
Biogen
BIIB
+$7.76M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$25.1M
2
MASI
Masimo
MASI
+$18.4M
3
GILD icon
Gilead Sciences
GILD
+$16.3M
4
ABT icon
Abbott
ABT
+$13.3M
5
LPNT
LifePoint Health, Inc.
LPNT
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 98.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
26
GSK
GSK
$103B
$5.55M 0.85%
+109,324
New +$5.55M
ACH
27
Accendra Health
ACH
$240M
$5.14M 0.78%
175,874
– –
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
$1.51M 0.23%
+39,173
New +$1.54M
MASI
29
DELISTED
Masimo
MASI
– –
-201,418
Closed -$18.4M
ALXN
30
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-40,300
Closed -$4.9M
LPNT
31
DELISTED
LifePoint Health, Inc.
LPNT
– –
-149,714
Closed -$10.1M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2017 Portfolio in Review

As of Q3 2017, Sector Gamma AS held 31 positions worth $656M, down 4.6% from $688M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS withdrew a net $44.4M in Q3 2017, closing 3 positions and reducing 14 holdings. Its most notable exit was Masimo, an estimated $18.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in AstraZeneca worth $25.1M.

  • Sector Gamma AS's largest Q3 2017 buy was AstraZeneca: 370,336 shares worth $25.1M.
  • Sector Gamma AS added most to Eli Lilly in Q3 2017, an estimated $20M increase.
  • Sector Gamma AS's biggest Q3 2017 reduction was Bristol-Myers Squibb, cutting an estimated $25.1M.
  • Sector Gamma AS fully exited Masimo in Q3 2017, selling an estimated $18.4M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $656M portfolio in Q3 2017.
  • Sector Gamma AS opened 5 new positions and closed 3 in Q3 2017.
  • Sector Gamma AS's portfolio value fell 4.6% quarter-over-quarter to $656M.

Based on Sector Gamma AS's 13F filing for Q3 2017, filed 7 Nov 2017.